Baird Medical Investment Holdings (BDMDW) Non-Current Deffered Revenue (2023)
Baird Medical Investment Holdings (BDMDW) recorded quarterly Non-Current Deffered Revenue of $875258.0 in Q4 2023.
Baird Medical Investment Holdings (BDMDW) Non-Current Deffered Revenue (2023) Analysis & Trends
Baird Medical Investment Holdings' Non-Current Deffered Revenue history runs 1 years deep, the most recent figure standing at $875258.0 for Q4 2023.
- In Q4 2023, Non-Current Deffered Revenue changed N/A year-over-year to $875258.0; the TTM figure through Dec 2023 stood at $875258.0 (changed N/A YoY), while the FY2023 annual figure was $875258.0, changed N/A from the prior year.
- Non-Current Deffered Revenue was $875258.0 for Q4 2023 at Baird Medical Investment Holdings.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $875258.0 in Q4 2023 to a low of $875258.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Baird Medical Investment Holdings | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 875,258.00 |